Breaking News Instant updates and real-time market news.

DCPH

Deciphera

$22.84

-0.12 (-0.52%)

04:55
04/16/19
04/16
04:55
04/16/19
04:55

Deciphera management to meet with JPMorgan

Meeting to be held in San Francisco/San Mateo on April 16 and in Los Angeles/San Diego on April 17 hosted by JPMorgan.

  • 16

    Apr

  • 17

    Apr

  • 07

    May

DCPH Deciphera
$22.84

-0.12 (-0.52%)

01/03/19
PIPR
01/03/19
NO CHANGE
PIPR
Piper sees Alexion, Biogen as potential targets after Celgene buyout
Piper Jaffray analyst Christopher Raymond remains "bullish on biotech" in the wake the announced acquisition of Celgene (CELG) by Bristol-Myers Squibb (BMY) for $74B in cash and stock, representing a 54% premium from yesterday's close. In a research note titled "Bristol for CELG - In Retrospect, it Makes Perfect Sense," Raymond says the market is likely to ask "who's next?" Among large-caps, Alexion Pharmaceuticals (ALXN) and Biogen (BIIB) would seem to make sense as potential targets, as well as BioMarin (BMRN), Raymond writes. And while any smid cap could likely be seen as a take-out candidate, Aimmune Therapeutics (AIMT), Deciphera Pharmaceuticals (DCPH) and Rigel Pharmaceuticals (RIGL) "in particular could make sense to any strategic buyer," adds the analyst.
03/06/19
PIPR
03/06/19
NO CHANGE
PIPR
Departure of Gottlieb brings some biopharma uncertainty, says Piper Jaffray
Piper Jaffray remains "largely bullish" on the biopharma sector but acknowledges a "new and unexpected" source of uncertainty now with the announced departure of FDA commissioner Scott Gottlieb, analysts led by Christopher Raymond tell investors in a research note. With a track record of favoring innovation and pushing for increased regulatory efficiency while also advocating for more competition, Dr. Gottlieb was about as "market friendly, patient focused and industry friendly as one could have hoped," Piper writes. The firm adds that while it has no reason to believe the next commissioner "will be quite as radical and potentially damaging to the industry," it does think investors would do well to watch the selection process very closely.
03/12/19
PIPR
03/12/19
NO CHANGE
PIPR
Biopharma stocks should be up sharply on Sharpless selection, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond said he expects biopharma stocks to be up sharply on news that former National Cancer Institute director Ned Sharpless will be named acting FDA commissioner. The biotech sector "experienced a swoon of sorts" since Scott Gottlieb announced his departure, but with the announcement of Gottlieb's favored choice as successor Raymond believes the FDA will remain "on its current industry-friendly and efficiency driven trajectory," the analyst tells investors.
03/14/19
PIPR
03/14/19
NO CHANGE
Target $50
PIPR
Overweight
Deciphera development of ripretinib 'progressing nicely', says Piper Jaffray
Piper Jaffray analyst Christopher Raymond kept his Overweight rating and $50 price target on Deciphera after its in-line Q4 results, saying the company's development of ripretinib is progressing nicely with ongoing phase 3 enrollment in INTRIGUE study and results for INVICTUS study expected later this year. The analyst remains positive on the shares given the company's "catalyst-rich" second half of the year on tap.

TODAY'S FREE FLY STORIES

FAF

First American

$56.18

0.17 (0.30%)

06:48
04/25/19
04/25
06:48
04/25/19
06:48
Earnings
First American reports Q1 EPS 74c, consensus 68c »

Reports Q1 revenue $1.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

  • 13

    Nov

NVT

nVent Electric

$28.40

0.19 (0.67%)

06:47
04/25/19
04/25
06:47
04/25/19
06:47
Earnings
nVent Electric reports Q1 adjusted EPS 39c , consensus 39c »

Reports Q1 revenue $538M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ENB

Enbridge

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Downgrade
Enbridge rating change  »

Enbridge downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

GBNXF

Gibson Energy

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Downgrade
Gibson Energy rating change  »

Gibson Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAD

Lithia Motors

$104.90

7.19 (7.36%)

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Upgrade
Lithia Motors rating change  »

Stephens upgrades Lithia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    May

  • 13

    Nov

BBU

Brookfield Business Partners

$37.80

-0.17 (-0.45%)

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Hot Stocks
Brookfield Business Partners selling BGRS for $230M in proceeds »

Brookfield Business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

CBZ

CBIZ

$20.59

-0.005 (-0.02%)

06:44
04/25/19
04/25
06:44
04/25/19
06:44
Earnings
CBIZ backs FY19 EPS view up 10%-12%, consensus $1.20 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 06

    Aug

NGD

New Gold

$0.88

0.0253 (2.96%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Earnings
New Gold reports Q1 adjusted EPS 0c, consensus 1c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

MTSI

Macom

$15.86

-0.33 (-2.04%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Downgrade
Macom rating change  »

Macom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

CBZ

CBIZ

$20.59

-0.005 (-0.02%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Earnings
CBIZ reports Q1 EPS 67c, consensus 70c »

Reports Q1 revenue $270M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 06

    Aug

BIP

Brookfield Infrastructure

$41.62

-0.03 (-0.07%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Downgrade
Brookfield Infrastructure rating change  »

Brookfield Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

WYNN

Wynn Resorts

$144.35

1.35 (0.94%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Upgrade
Wynn Resorts rating change  »

Wynn Resorts upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ALXN

Alexion

$130.12

-2.24 (-1.69%)

06:41
04/25/19
04/25
06:41
04/25/19
06:41
Earnings
Alexion raises FY19 adj. EPS view to $9.25-$9.45 from $9.10-$9.30 »

FY19 consensus $9.31.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 06

    May

  • 14

    May

  • 28

    Jun

LUV

Southwest

$52.92

0.11 (0.21%)

06:40
04/25/19
04/25
06:40
04/25/19
06:40
Earnings
Southwest reports Q1 EPS 70c, consensus 61c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 21

    May

  • 13

    Nov

MMM

3M

$219.24

-0.28 (-0.13%)

06:39
04/25/19
04/25
06:39
04/25/19
06:39
Hot Stocks
Breaking Hot Stocks news story on 3M »

3M drops 6% to $205.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

EQT

EQT Corporation

$20.75

-0.26 (-1.24%)

06:39
04/25/19
04/25
06:39
04/25/19
06:39
Earnings
EQT Corporation reports Q1 adjusted EPS 83c, consensus 74c »

Reports Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ALXN

Alexion

$130.12

-2.24 (-1.69%)

06:38
04/25/19
04/25
06:38
04/25/19
06:38
Earnings
Alexion reports Q1 adjusted EPS $2.39, consensus $2.19 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 06

    May

  • 14

    May

  • 28

    Jun

BWA

BorgWarner

$43.50

-0.135 (-0.31%)

06:38
04/25/19
04/25
06:38
04/25/19
06:38
Earnings
BorgWarner backs FY19 EPS view $4.00-$4.35, consensus $4.20 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SSNLF

Samsung

$0.00

(0.00%)

, BTC

Bitcoin

$0.00

(0.00%)

06:37
04/25/19
04/25
06:37
04/25/19
06:37
Periodicals
Samsung plans to develop its own Ethereum-based blockchain, token, TNW reports »

Samsung is planning to…

SSNLF

Samsung

$0.00

(0.00%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLO

Valero

$87.75

-2.53 (-2.80%)

06:36
04/25/19
04/25
06:36
04/25/19
06:36
Hot Stocks
Valero says expects to invests about $2.5B of capital in 2019, 2020 »

The Houston alkylation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

BWA

BorgWarner

$43.50

-0.135 (-0.31%)

06:36
04/25/19
04/25
06:36
04/25/19
06:36
Earnings
BorgWarner sees Q2 adj. EPS 99c-$1.05, consensus $1.07 »

Sees Q2 organic sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

VLO

Valero

$87.75

-2.53 (-2.80%)

06:36
04/25/19
04/25
06:36
04/25/19
06:36
Earnings
Valero reports Q1 EPS 34c, consensus 29c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

XRX

Xerox

$33.68

-0.53 (-1.55%)

06:35
04/25/19
04/25
06:35
04/25/19
06:35
Earnings
Xerox raises 2019 adjusted EPS view to $3.80-$3.95 from $3.70-$3.80 »

Consensus for 2019 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 21

    May

MMM

3M

$219.24

-0.28 (-0.13%)

06:35
04/25/19
04/25
06:35
04/25/19
06:35
Hot Stocks
3M CEO says 'the first quarter was a disappointing start to the year' »

"The first quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

MMM

3M

$219.24

-0.28 (-0.13%)

06:34
04/25/19
04/25
06:34
04/25/19
06:34
Hot Stocks
3M sees FY19 organic local-currency sales growth (1%)-2% »

"3M also updated its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.